|
Takeda
|
4,168.00 |
|
-22.00 |
-0.53% |
1.88% |
2025-04-17 |
|
Acadia Pharmaceuticals
|
14.58 |
|
-0.41 |
-2.74% |
-15.18% |
2025-04-16 |
|
Agios Pharmaceuticals
|
27.15 |
|
-0.67 |
-2.41% |
-6.48% |
2025-04-16 |
|
Alnylam Pharmaceuticals
|
230.50 |
|
-0.43 |
-0.19% |
58.62% |
2025-04-16 |
|
Amgen
|
282.84 |
|
-12.60 |
-4.26% |
7.04% |
2025-04-16 |
|
Arrowhead Research
|
11.35 |
|
-1.52 |
-11.81% |
-49.62% |
2025-04-16 |
|
Tectonic Therapeutic
|
17.56 |
|
-0.38 |
-2.12% |
19.90% |
2025-04-16 |
|
BioMarin Pharmaceutical
|
58.83 |
|
-1.19 |
-1.98% |
-34.97% |
2025-04-16 |
|
Incyte
|
57.73 |
|
-0.73 |
-1.25% |
9.36% |
2025-04-16 |
|
Ionis Pharmaceuticals
|
28.35 |
|
-0.03 |
-0.11% |
-30.70% |
2025-04-16 |
|
Moderna
|
25.19 |
|
-1.04 |
-3.95% |
-75.66% |
2025-04-16 |
|
Neurocrine Biosciences
|
100.10 |
|
3.94 |
4.10% |
-24.87% |
2025-04-16 |
|
Novartis
|
109.57 |
|
-0.25 |
-0.23% |
17.83% |
2025-04-16 |
|
PTC Therapeutics
|
46.46 |
|
-0.48 |
-1.02% |
84.66% |
2025-04-16 |
|
Ultragenyx Pharmaceutical
|
34.98 |
|
-0.36 |
-1.02% |
-20.70% |
2025-04-16 |
|
Regeneron Pharmaceuticals
|
549.97 |
|
-7.97 |
-1.43% |
-39.00% |
2025-04-16 |
|
Sanofi
|
50.57 |
|
-0.03 |
-0.05% |
10.34% |
2025-04-16 |
|
Sarepta Therapeutics
|
53.94 |
|
-0.48 |
-0.88% |
-54.25% |
2025-04-16 |
|
Vertex Pharmaceuticals
|
486.21 |
|
-14.14 |
-2.83% |
23.55% |
2025-04-16 |
|
Xencor
|
9.53 |
|
-0.01 |
-0.10% |
-50.03% |
2025-04-16 |